Chinese herbal medicine for schizophrenia: Cochrane systematic review of randomised trials

British Journal of Psychiatry

Volumn 190, Issue MAY, 2007, Pages 379-384

  Rathbone, John ^a   Zhang, Lan ^b   Zhang, Mingming ^b   Xia, Jun ^a   Liu, Xiehe ^b   Yang, Yanchun ^b   Adams, Clive E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; GINKGO BILOBA EXTRACT; HALOPERIDOL; HERBACEOUS AGENT; HIRUDO EXTRACT; NEUROLEPTIC AGENT; PERPHENAZINE; PLACEBO; RHEUM PALMATUM EXTRACT; SULPIRIDE; UNCLASSIFIED DRUG; XINGSHEN;

CHINESE HERB; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; HUMAN; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TRADITIONAL MEDICINE;

ANTIPSYCHOTIC AGENTS; COMBINED MODALITY THERAPY; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 34248161656     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.106.026880     Document Type: Review

References (25)

1. Adams, C. E., Avrad, G., Rathbone, J., et al (2007) Chlorpromazine versus placebo for schizophrenia. Cochrane Database of Systematic Reviews, issue 2. Wiley.
2. Alderson, P., Green, S. & Higgins, J. P. T. (2004) Cochrane Reviewers' Handbook 4.2.2. Cochrane Library, issue 1. Wiley.
3. Altman, D. G. & Bland. J. M. (1996) Detecting skewness from summary information. BMJ, 313, 1200.
4. Brenner, H. D., Dencker, S. J., Goldstein, M. J., et al (1990) Defining treatment refractoriness in schizophrenia. Schizophrenia Bulletin, 16, 551-561.
5. Cao, X. D. & Wang, W. (2000) Comparison between therapeutic effect of risperidone in treating different traditional Chinese medicine syndrome types of first-episode schizophrenia. Chinese Journal of Integrated Traditional and Western Medicine, 20, 421-423.
6. Chen, Y. D., He, A. N. & Chen, L. (1997) The clinical observation on 120 cases of schizophrenic negative symptoms treated with 'Xin Shen' mixture. Journal of University Traditional Chinese Medicine, 22, 19-21.
7. Gong, M. F., Zu, Y. M., Jin, P., et al (2000) Clinical investigation of Qingnao Anshen decoction on hemorrheology in the patients with schizophrenia and depression. Hebei Journal of Traditional Chinese Medicine, 22, 571-573.
8. Han, B., Zhang, M., Liu, L., et al (2002) A double blind controlled trial of traditional Chinese medicine and clozapine in schizophrenia (abstract). International Journal of Neuropsychopharmacology, 5 (suppl. 1), 190.
9. Higgins, J. P., Thompson, S. G., Deeks, J. J., et al (2003) Measuring inconsistency in meta-analyses. BMJ, 327, 557-560.
10. Luo, H. C., Shen, Y. & Meng, F. Q. (1997) Therapeutic effect of shuxuening combining neuroleptics for the treatment of chronic schizophrenia - a double blind study. Chung-Kuo Chung Hsi I Chieh Ho Tsa Chih, 17, 139-142.
11. Meng, F. Q., Cui, Y. H. & Wang, S. H. (1996) A double-blind placebo controlled study of EGb761 in the treatment of chronic schizophrenia. Journal of Clinical Psychological Medicine, 6, 339-341.
12. Ming, Z. (2001) The Medical Classic of the Yellow Emperor. Foreign Language Press.
13. Moher, D., Schulz, K. F. & Altman, D. (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA, 285, 1987-1991.
14. Rathbone, J., Zhang, L., Zhang, M., et al (2005) Chinese herbal medicine for schizophrenia. Cochrane Database of Systematic Reviews, issue 4. Wiley.
15. Rong, Y. (2001) Controlled treatment of Que-Dian decoction with low dosage of clozapine in treating schizophrenia. Zhe Jiang Zhong Xi Yi Jie He Za Zhi, II, 470-471.
16. Saku, M. (1991) The current clinical practice of herbal medicine in psychiatry in mainland China: a review of literature. Japanese Journal of Psychiatry and Neurology, 45, 825-832.
17. Wang, B. (1998a) Traditional Chinese medical treatment to invigorate blood and relieve stasis treatment of schizophrenia: comparison with antipsychotic treatment. Psychiatry and Clinical Neuroscience, 52, 329-330.
18. Wang, B. (1998b) A controlled study of the efficacy of Chinese herb medicine in schizophrenic patients. Chinese Journal of Neurology and Psychiatry, 18, 44-46.
19. Zhang, J. (1996) Current status of integrated traditional and Western medicine study on schizophrenia. Chinese Journal of Integrated Traditional and Western medicine, 16, 643-645.
20. Zhang, L. D., Tang, Y. H., Zhu, W. B., et al (1987) Comparative study of schizophrenia treatment with electroacupuncture, herbs and chlorpromazine. Chinese Medical Journal, 100, 152-157.
21. Zhang, L. D., Zhou, G. & Jin, Z. Y. (1997) Biochemical study on TCM treatment of schizophrenia based on syndrome typing. Journal of Traditional Chinese Medicine, 38, 173-175.
22. Zhang, Y. Z., Zhou, D. F., Zhang, P. Y., et al (2001) A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. Journal of Clinical Psychiatry, 62, 878-883.
23. Zhao, X. Y., He, M. & Luo, H. (1997) Effects of Ginkgo biloba special extract Egb761 on nailfold microcirculation and symptoms of chronic schizophrenics. Chinese Journal of Microcirculation, 7, 25-27.
24. Zhen, H. B. & Feng, R. S. (1992) Chinese drug therapy in treatment of schizophrenia. Chinese Journal of Nervous and Mental Disorders, 18, 362-363.
25. Zhu, Y. Z., Kang, B. & Zhu, Q. Q. (1996) Clinical study of shuizhi-dahuang mixture in treating schizophrenics with blood stasis syndrome. Chung-Kuo Chung Hsi i Chieh Ho Tsa Chih, 16, 646-648.